These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


260 related items for PubMed ID: 4629908

  • 1. Modulation of pituitary responsiveness to thyrotropin-releasing hormone by triiodothyronine.
    Shenkman L, Mitsuma T, Hollander CS.
    J Clin Invest; 1973 Jan; 52(1):205-9. PubMed ID: 4629908
    [Abstract] [Full Text] [Related]

  • 2. Repetitive administration of thyrotropin-releasing hormone results in small elevations of serum thyroid hormones and in marked inhibition of thyrotropin response.
    Snyder PJ, Utiger RD.
    J Clin Invest; 1973 Sep; 52(9):2305-12. PubMed ID: 4199417
    [Abstract] [Full Text] [Related]

  • 3. Pituitary unresponsiveness to thyrotropin-releasing hormone in thyrotoxic patients during chronic anti-thyroid drug therapy and in rats previously treated with excess thyroid hormone.
    Harada A, Kojima A, Tsukui T, Onaya T, Yamada T, Ikejiri K, Yukimura Y.
    J Clin Endocrinol Metab; 1975 Jun; 40(6):942-8. PubMed ID: 805794
    [Abstract] [Full Text] [Related]

  • 4. Thyroid hormone inhibition of the prolactin response to thyrotropin-releasing hormone.
    Snyder PJ, Jacobs LS, Utiger RD, Daughaday WH.
    J Clin Invest; 1973 Sep; 52(9):2324-9. PubMed ID: 4199418
    [Abstract] [Full Text] [Related]

  • 5. Serum concentrations of thyroxine, 3,5,3'-triiodothyronine, thyrotropin, and prolactin in dogs before and after thyrotropin-releasing hormone administration.
    Kaufman J, Olson PN, Reimers TJ, Allen TA, Soderberg SF, Nett TM, Wheeler SL, Wingfield WE.
    Am J Vet Res; 1985 Feb; 46(2):486-92. PubMed ID: 3922262
    [Abstract] [Full Text] [Related]

  • 6. Dissociation of responsiveness to thyrotropin-releasing hormone and thyroid suppressibility following antithyroid drug therapy of hyperthyroidism.
    Martino E, Pinchera A, Capiferri R, Macchia E, Sardano G, Bartalena L, Mazzanti F, Baschieri L.
    J Clin Endocrinol Metab; 1976 Sep; 43(3):543-9. PubMed ID: 821960
    [Abstract] [Full Text] [Related]

  • 7. Pituitary-thyroid responsiveness to intramuscular thyrotropin-releasing hormone based on analyses of serum thyroxine, tri-iodothyronine and thyrotropin concentrations.
    Azizi F, Vagenakis AG, Portnay GI, Rapoport B, Ingbar SH, Braverman LE.
    N Engl J Med; 1975 Feb 06; 292(6):273-7. PubMed ID: 803298
    [Abstract] [Full Text] [Related]

  • 8. Suppression of pituitary TSH secretion in the patient with a hyperfunctioning thyroid nodule.
    Ridgway EC, Weintraub BD, Cevallos JL, Rack MC, Maloof F.
    J Clin Invest; 1973 Nov 06; 52(11):2783-92. PubMed ID: 4201265
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of thyrotropin response to thyrotropin-releasing hormone by small quantities of thyroid hormones.
    Snyder PJ, Utiger RD.
    J Clin Invest; 1972 Aug 06; 51(8):2077-84. PubMed ID: 4626582
    [Abstract] [Full Text] [Related]

  • 10. Time-dependent effects of oral thyrotropin-releasing hormone in hyperthyroid female rats.
    Iglesias R, Llobera M, Montoya E.
    Horm Metab Res; 1986 Jul 06; 18(7):454-6. PubMed ID: 3091472
    [Abstract] [Full Text] [Related]

  • 11. Pituitary-thyroid regulation in euthyroid patients with Graves' disease previously treated with antithyroid drugs.
    Buerklin EM, Schimmel M, Utiger RD.
    J Clin Endocrinol Metab; 1976 Aug 06; 43(2):419-27. PubMed ID: 59733
    [Abstract] [Full Text] [Related]

  • 12. Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis.
    Sato A, Yamada T, Aizawa T, Ichikawa K, Komiya I, Takasu N, Takemura Y.
    J Clin Endocrinol Metab; 1995 Jul 06; 80(7):2173-7. PubMed ID: 7608274
    [Abstract] [Full Text] [Related]

  • 13. Serum levels of thyrotropin, prolactin, growth hormone, triiodothyronine and thyroxine after oral administration of thyrotropin releasing hormone in hypothyroid and hyperthyroid patients.
    Nedvídková J, Felt V.
    Endokrinologie; 1976 Jul 06; 68(2):175-82. PubMed ID: 827434
    [Abstract] [Full Text] [Related]

  • 14. [Variation of the thyrotropin-releasing-hormone (TRH) stimulated thyrotropin (TSH) response in comparison with the tyhroid-gland-suppression test and the triiodothyronine (T3) and thyroxine (T4) blood levels in the so-called euthyroid endocrine ophthalmopathy].
    Wenzel KW.
    Endokrinologie; 1975 Sep 06; 66(1):67-73. PubMed ID: 1243821
    [Abstract] [Full Text] [Related]

  • 15. Propylthiouracil blocks extrathyroidal conversion of thyroxine to triiodothyronine and augments thyrotropin secretion in man.
    Geffner DL, Azukizawa M, Hershman JM.
    J Clin Invest; 1975 Feb 06; 55(2):224-9. PubMed ID: 805160
    [Abstract] [Full Text] [Related]

  • 16. Thyroid-stimulating hormone (tsh), triiodothyronine (t3) and thyroxine (t4) response to intravenous and oral stimulation with synthetic thyrotropin-releasing hormone (trh) in young healthy adults.
    Vogt P, Girard J, Staub JJ.
    Klin Wochenschr; 1978 Jan 01; 56(1):31-5. PubMed ID: 415173
    [Abstract] [Full Text] [Related]

  • 17. Hyperresponse to thyrotropin-releasing hormone accompanying small decreases in serum thyroid hormone concentrations.
    Vagenakis AG, Rapoport B, Azizi F, Portnay GI, Braverman LE, Ingbar SH.
    J Clin Invest; 1974 Oct 01; 54(4):913-8. PubMed ID: 4214837
    [Abstract] [Full Text] [Related]

  • 18. Serum thyrotropin and prolactin in the syndrome of generalized resistance to thyroid hormone: responses to thyrotropin-releasing hormone stimulation and short term triiodothyronine suppression.
    Sarne DH, Sobieszczyk S, Ain KB, Refetoff S.
    J Clin Endocrinol Metab; 1990 May 01; 70(5):1305-11. PubMed ID: 2110573
    [Abstract] [Full Text] [Related]

  • 19. Thyrotropin-releasing hormone and thyroid hormone interactions on thyrotropin secretion in the rat: lack of inhibiting effects of small doses of triiodo-L-thyronine in the hypothyroid rat.
    García MD, Escobar del Rey F, Morreale de Escobar G.
    Endocrinology; 1976 Jan 01; 98(1):203-13. PubMed ID: 813987
    [Abstract] [Full Text] [Related]

  • 20. Sustained rises in serum thyrotropin, thyroxine, and triiodothyronine during long term, continuous thyrotropin-releasing hormone treatment in patients with amyotrophic lateral sclerosis.
    Kaplan MM, Taft JA, Reichlin S, Munsat TL.
    J Clin Endocrinol Metab; 1986 Oct 01; 63(4):808-14. PubMed ID: 3091628
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.